AAPL 242.195 -3.2845% MSFT 415.4 -1.4472% NVDA 136.11 1.3553% GOOGL 188.45 -0.449% GOOG 189.67 -0.4043% AMZN 218.77 -0.2826% META 592.1525 1.1345% AVGO 230.54 -0.5607% TSLA 377.02 -6.6412% TSM 199.64 1.0887% LLY 774.59 0.3355% V 312.71 -1.0537% JPM 239.57 -0.0584% UNH 504.27 -0.3143% NVO 87.56 1.7903% WMT 89.7 -0.7194% LVMUY 128.99 -1.3008% XOM 107.02 -0.5113% LVMHF 645.0 -1.7816% MA 518.315 -1.5677%

Envoy Medical Inc.

Healthcare US COCH

1.525USD
0.10(6.64%)

Last update at 2025-01-02T19:00:00Z

Day Range

1.401.68
LowHigh

52 Week Range

0.7511.72
LowHigh

Fundamentals

  • Previous Close 1.43
  • Market Cap26.39M
  • Volume15848
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-14.43100M
  • Revenue TTM0.24M
  • Revenue Per Share TTM0.002
  • Gross Profit TTM -0.72000M
  • Diluted EPS TTM-1.97

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -29.90800M -15.92300M -8.67500M -0.00070M
Minority interest - - - -
Net income -29.90800M -15.92300M -8.67500M -0.00070M
Selling general administrative 7.28M 3.47M 2.47M -
Selling and marketing expenses 1.67M 0.89M - -
Gross profit -0.60600M -0.72000M -0.45900M -
Reconciled depreciation 0.11M 0.07M 0.07M -
Ebit -18.37100M -8.70600M -6.87100M -
Ebitda -18.23800M -8.63100M -6.80000M -0.00070M
Depreciation and amortization 0.13M 0.07M 0.07M -
Non operating income net other - - - -
Operating income -18.37100M -8.70600M -6.87100M -0.00070M
Other operating expenses 18.69M 8.94M 7.18M 0.00070M
Interest expense - - - -
Tax provision - - - -
Interest income - - - -
Net interest income - - - -
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense - - - -
Total revenue 0.32M 0.24M 0.31M -
Total operating expenses 17.77M 7.99M 6.41M 0.00070M
Cost of revenue 0.92M 0.96M 0.77M -
Total other income expense net -11.53700M -7.21700M -1.80400M -0.00000M
Discontinued operations - - - -
Net income from continuing ops -36.50400M -15.92300M -8.67500M -
Net income applicable to common shares - -17.92300M -10.67500M -
Preferred stock and other adjustments - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 7.64M 2.56M 2.62M 0.12M
Intangible assets - - - -
Earning assets - - - -
Other current assets 0.96M 0.13M 0.00071M -
Total liab 9.40M 58.72M 47.58M 0.10M
Total stockholder equity -1.76200M -56.16800M -44.96000M 0.02M
Deferred long term liab - - - -
Other current liab 4.92M 0.93M 0.71M -
Common stock 0.00200M 1.39M 1.39M 0.00121M
Capital stock - 1.39M 1.39M -
Retained earnings -257.24200M -225.98500M -210.06200M -0.00070M
Other liab - 2.27M 2.75M -
Good will - - - -
Other assets 0.00000M - - -
Cash 4.22M 0.18M 1.12M 0.03M
Cash and equivalents - - - -
Total current liabilities 6.64M 2.52M 1.38M 0.10M
Current deferred revenue - 0.01M 0.01M -
Net debt -3.65600M 34.35M 22.36M -0.02500M
Short term debt 0.16M 0.57M 0.46M -
Short long term debt - 0.45M - -
Short long term debt total 0.56M 34.53M 23.48M -
Other stockholder equity 255.60M 168.54M 163.82M 0.02M
Property plant equipment - 0.91M 0.19M -
Total current assets 6.83M 1.65M 2.44M 0.03M
Long term investments - - - -
Net tangible assets - -56.16800M -44.96000M -
Short term investments - - - -
Net receivables 0.25M 0.04M 0.09M -
Long term debt - 33.40M 23.48M -
Inventory 1.40M 1.29M 1.06M -
Accounts payable 1.55M 1.00M 0.66M 0.10M
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income -0.11800M -0.11500M -0.10800M -
Additional paid in capital - - - -
Common stock total equity - - - -
Preferred stock total equity - - - -
Retained earnings total equity - - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other -0.00000M - -0.42504M 0.09M
Deferred long term asset charges - - - -
Non current assets total 0.81M 0.91M 0.19M 0.09M
Capital lease obligations - 0.69M 0.00000M -
Long term debt total - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31
Investments -0.17300M -0.21800M -0.12500M
Change to liabilities - 0.34M 0.23M
Total cashflows from investing activities - -0.21800M -0.12500M
Net borrowings - 8.00M 8.00M
Total cash from financing activities 21.84M 8.09M 8.06M
Change to operating activities - -0.35500M -0.34500M
Net income -29.90800M -15.92300M -8.67500M
Change in cash 4.04M -0.93800M 0.99M
Begin period cash flow 0.18M 1.12M 0.13M
End period cash flow 4.22M 0.18M 1.12M
Total cash from operating activities -17.65400M -8.80500M -6.93600M
Issuance of capital stock - - -
Depreciation 0.13M 0.07M 0.07M
Other cashflows from investing activities - - -
Dividends paid - - -
Change to inventory -0.01000M -0.19400M 0.06M
Change to account receivables -0.20500M 0.05M -0.01900M
Sale purchase of stock - - -
Other cashflows from financing activities 11.85M 0.09M 8.06M
Change to netincome - 7.20M 1.75M
Capital expenditures 0.15M 0.22M 0.12M
Change receivables - - -
Cash flows other operating - - -
Exchange rate changes - - -
Cash and cash equivalents changes - - -
Change in working capital -0.95800M -0.16000M -0.08200M
Stock based compensation 1.57M - -
Other non cash items 13.01M 7.20M 1.75M
Free cash flow -17.80700M -9.02300M -7.06100M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
COCH
Envoy Medical Inc.
0.10 6.64% 1.52 - - 109.51 4.22 81.08 -1.3541
ABT
Abbott Laboratories
-0.27 0.24% 112.84 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation
-2.75 0.76% 357.30 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC
0.01 0.01% 79.89 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp
-0.41 0.46% 88.91 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

Profile

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

Envoy Medical Inc.

4875 White Bear Parkway, White Bear Lake, MN, United States, 55110

Key Executives

Name Title Year Born
Mr. Brent T. Lucas Esq. CEO & Director 1983
Mr. David R. Wells Chief Financial Officer 1962

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.